NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,548,000 | -48.5% | 48,168 | 0.0% | 0.02% | -41.2% |
| Q4 2021 | $6,891,000 | -69.4% | 48,168 | -55.7% | 0.03% | -65.7% |
| Q3 2021 | $22,546,000 | -26.1% | 108,756 | -24.3% | 0.10% | -26.1% |
| Q2 2021 | $30,521,000 | +17.1% | 143,756 | 0.0% | 0.13% | +18.6% |
| Q1 2021 | $26,064,000 | +37.7% | 143,756 | -15.3% | 0.11% | +59.2% |
| Q4 2020 | $18,924,000 | -6.8% | 169,706 | -9.4% | 0.07% | -12.3% |
| Q3 2020 | $20,302,000 | +0.9% | 187,376 | -22.4% | 0.08% | -9.0% |
| Q2 2020 | $20,119,000 | – | 241,376 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |